This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Avantis Emerging Markets Equity ETF (AVEM - Free Report) is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 17.06% from its 52-week low price of $50.65/share.
Are more gains in store for this ETF? Let us take a quick look at the fund and the near-term outlook on it to get a better idea of where it might be headed.
AVEM in Focus
The fund employs an active strategy seeking long-term capital appreciation by investing primarily in a diverse group of companies related to emerging markets across market sectors, industry groups and countries. The fund has major exposure to China (23%), India (20%) and Taiwan (19%). The product charges 9 bps in annual fees (see: Broad Emerging Market ETFs).
Why the Move?
The emerging market (EM) has been an area to watch lately, supported by the ongoing U.S.-led global economic growth. Anticipated monetary policy loosening in the United States and the eurozone further contributes to the improving outlook for EMs. Moderating inflation level fueling investor confidence, along with the likelihood of many EMs opting for interest rate cuts in 2024, bode well for EM funds.
More Gains Ahead?
AVEM might continue its strong performance in the near term, with a positive weighted alpha of 12.42, which gives cues of a further rally.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.
Get it free >>
Get the latest research report on AVEM - FREE